Drawing for BIOPTIMUS

USPTO serial 98351159

BIOPTIMUS

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
Examiner
WATTS-FITZGERALD, CAITLIN C
Law office
TMO LAW OFFICE 111

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOPTIMUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ANDREW D. BOCHNER

ANDREW D. BOCHNER BOCHNER PLLC1040 AVENUE OF THE AMERICAS15TH FLOORNEW YORK, NY 10018

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software using artificial intelligence and machine learning for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences; Downloadable software using artificial intelligence for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences specifically related to healthcare; Downloadable computer software and programs using artificial intelligence for data and software processing, data generation, and for understanding and analyzing that data; downloadable computer programs and downloadable computer software using artificial intelligence for developing, running and analyzing algorithms that are able to learn to analyze, classify, and take actions in response to exposure to data; downloadable computer software for use in simulation environments for the purpose of testing artificial intelligence agents, algorithms and programs; downloadable computer software and programs for diagnosing health conditions, prescribing treatments and writing prescriptions, designing clinical tests and forecasting clinical test results, searching for clinical trial participants, analysing medical images, analysing data, and developing pharmaceuticals and chemical compoundsACTIVE
042Software as a service (SAAS) services featuring software using artificial intelligence for performing and recording research, and for performing diagnostic tests in the fields of biology, pharmacology, bioengineering and life sciences; Research in the field of artificial intelligence technology; technology consulting in the field of artificial intelligence; Software as a service (SaaS) services featuring software for diagnosing health conditions, prescribing treatments and writing prescriptions, designing clinical tests and forecasting clinical test results, searching for clinical trial participants, analyzing medical images, analyzing data, and developing pharmaceuticals and chemical compounds; Scientific and technological services, namely, research in the fields of biotechnology, drug discovery and development, and diagnostic preparations; Advisory services relating to scientific research; Scientific research; Engineering services; Technical consultancy services relating to computer programming; Research and development services in the field of engineering; Development of computer programs; Software design and developmentACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2025MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jul 16, 2025ABN3ABANDONMENT - AFTER EX PARTE APPEAL
Jul 16, 2025EXPTEXPARTE APPEAL TERMINATED
Jun 5, 2025EXFBEXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Feb 21, 2025GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Feb 21, 2025GECDACTION DENYING REQ FOR RECON E-MAILED
Feb 21, 2025CNCFACTION CONTINUING FINAL - COMPLETED
Feb 20, 2025EXPIEX PARTE APPEAL-INSTITUTED
Feb 20, 2025JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 20, 2025EXAFEXPARTE APPEAL RECEIVED AT TTAB
Feb 19, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 19, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Nov 19, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 19, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 7, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2024DOCKASSIGNED TO EXAMINER
Apr 30, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2024NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance